Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations

Charles E. Argoff(Albany Medical Center Hospital), Lynn R. Webster(Adherent Technologies (United States)), Daniel P. Alford(Boston University), Jeffrey Fudin(University of Connecticut), Jeremy Adler, Bill McCarberg(American Academy of Arts and Sciences), Richard C. Dart(Washington Poison Center), Jeffrey Gudin(Rutgers, The State University of New Jersey), Rosemary C. Polomano(University of Pennsylvania), Roy Gandolfi(Intermountain Healthcare), Matthew J. Bair(Regenstrief Institute), Steven P. Stanos(Pain and Headache Center)
Pain Medicine
November 9, 2017
10.1093/pm/pnx285
Cited by 66

Related Papers

Depression and Pain Comorbidity
|Archives of Internal Medicine|2003|3.4k
Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
|Journal of Pain|2016|3.2k
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
|Nature|2012|1.6k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain
|JAMA|2018|980